Moreover, Zhang et al. described elevated CD47 expression in multiple NSCLC lines refractory to treatment with anti-angiogenic VEGF inhibitors, which was induced by TNFα/NF-κB signaling. The gene discussed is CD47; the disease is non-small cell lung carcinoma.